Maximum Strength Non-aspirin 250
Acetaminophen
Jhk Inc Dba American Safety & First Aid
Human Otc Drug
NDC 73598-1124Maximum Strength Non-aspirin 250 also known as Acetaminophen is a human otc drug labeled by 'Jhk Inc Dba American Safety & First Aid'. National Drug Code (NDC) number for Maximum Strength Non-aspirin 250 is 73598-1124. This drug is available in dosage form of Tablet. The names of the active, medicinal ingredients in Maximum Strength Non-aspirin 250 drug includes Acetaminophen - 500 mg/1 . The currest status of Maximum Strength Non-aspirin 250 drug is Active.
Drug Information:
| Drug NDC: | 73598-1124 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Maximum Strength Non-aspirin 250 |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Acetaminophen |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Jhk Inc Dba American Safety & First Aid |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Tablet |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | ACETAMINOPHEN - 500 mg/1
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | ORAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 02 Feb, 2000 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 22 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part343 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | JHK Inc dba American Safety & First Aid
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 198440
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | 362O9ITL9D
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 73598-1124-1 | 125 DOSE PACK in 1 BOX (73598-1124-1) / 2 TABLET in 1 DOSE PACK | 02 Feb, 2000 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose pain reliever/fever reducer
Product Elements:
Maximum strength non-aspirin 100 acetaminophen acetaminophen acetaminophen starch, corn microcrystalline cellulose povidone, unspecified sodium starch glycolate type a stearic acid az235 maximum strength non-aspirin 250 acetaminophen acetaminophen acetaminophen starch, corn microcrystalline cellulose povidone, unspecified sodium starch glycolate type a stearic acid az235
Indications and Usage:
Use temporarily relieves fever and minor aches and pains associated with: headache backache muscular aches minor arthritis pain common cold toothaches menstrual cramps
Warnings:
Warnings liver warning this product contains acetaminophen. severe liver damage may occur if you take: more than 8 tablets (4000mg of acetaminophen) in 24 hours, which is the maximum daily amount with other drugs containing acetaminophen 3 or more alcoholic drinks every day while using this product do not use with any other drug containing acetaminophen (prescription or nonprescription). if you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist ask a doctor before use if you have liver disease. ask a doctor or pharmacist before use if you are taking the blood thinning drug warfarin. stop use and ask doctor if pain gets worse or lasts more than 10 days fever gets worse or lasts more than 3 days new symptoms occur redness or swelling is present. these could be signs of a serious condition. if pregnant or breast-feeding , ask a health professional before use. keep out of reach of children. overdose warning taking more than the recommended dose (overdose) may ca
Read more...use liver damage. in case of overdose, get medical help or contact a poison control center right away. prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
Do Not Use:
Warnings liver warning this product contains acetaminophen. severe liver damage may occur if you take: more than 8 tablets (4000mg of acetaminophen) in 24 hours, which is the maximum daily amount with other drugs containing acetaminophen 3 or more alcoholic drinks every day while using this product do not use with any other drug containing acetaminophen (prescription or nonprescription). if you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist ask a doctor before use if you have liver disease. ask a doctor or pharmacist before use if you are taking the blood thinning drug warfarin. stop use and ask doctor if pain gets worse or lasts more than 10 days fever gets worse or lasts more than 3 days new symptoms occur redness or swelling is present. these could be signs of a serious condition. if pregnant or breast-feeding , ask a health professional before use. keep out of reach of children. overdose warning taking more than the recommended dose (overdose) may cause liver damage. in case of overdose, get medical help or contact a poison control center right away. prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
Dosage and Administration:
Directions adults and children 12 years of age and older: take 2 tablets every 4 to 6 hours as needed; do not exceed 8 tablets in 24 hours, or as directed by a doctor children under 12 years of age: do not use this product; this will provide more than the recommended dose (overdose) of acetaminophen and could cause serious health concerns
Stop Use:
Stop use and ask doctor if pain gets worse or lasts more than 10 days fever gets worse or lasts more than 3 days new symptoms occur redness or swelling is present. these could be signs of a serious condition.
Package Label Principal Display Panel:
Principal display panel - 100 tablet box product #1122 maximum strength non-aspirin active ingredient: acetaminophen pain reliever/fever reducer temporary relief from minor aches, pain, and fever soothes muscles aches and minor arthritis pain non-drowsy, aspirin-free formula these quality comfort tablets are formulated and packaged for use in the workplace and meet ansi z308. 1-2015 standards. they are sealed in tamper-evident packets for safety and convenience. 100 tablets ⢠2 tablets per packet principal display panel
Principal display panel - 250 tablet box product #1124 maximum strength non-aspirin active ingredient: acetaminophen pain reliever/fever reducer temporary relief from minor aches, pain, and fever soothes muscles aches and minor arthritis pain non-drowsy, aspirin-free formula these quality comfort tablets are formulated and packaged for use in the workplace and meet ansi z308. 1-2015 standards. they are sealed in tamper-evident packets for safety and convenience. 250 tablets ⢠2 tablets per packet principal display panel
Further Questions:
Questions? 1-866-651-3660 monday-friday 8:00am-5:00pm est